A.1.a. SCI (Science Citation Index), SCI Expanded, SSCI (Social Science Citation Index) kapsamındaki dergilerde yayınlanan Makaleler 1. Yilmaz R, Akoglu H, Altun B, Yildirim T, Arici M, Erdem Y. Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients. Eur J Clin Nutr. 2012 Nov;66(11):1214-8. doi: 10.1038/ejcn.2012.110 (SCI). 2. Yilmaz R, Arici M, Yildirim T, Sahiner L, Aytemir K, Altun B, Erdem Y, Turgan C. Supplementary ultrafiltration may improve inflammation and cardiac dysfunction in patients with high interdialytic weight gain. Blood Purif. 2012;34(1):67-74. doi: 10.1159/000341553. Epub 2012 Aug 24 (SCI). 3. R Yilmaz, B Altun, S Kahraman, N Ozer, Akinci D, C Turgan, "Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients", Renal Failure (ISI) , 903–912 pp., 2010 , DOI: 10.3109/0886022X.2010.502276 (SCI-EXP). 4. R. Yılmaz, B. Altun, N Ozer, T. Hazirolan, C. Turgan, "Impact of cytokine genotype on cardiovascular surrogate markers in hemodialysis patients.", Renal Failure (ISI) , 806-16 pp., 2010 , DOI: 10.3109/0886022X.2010.494798 (SCI-EXP) 5. R. Yilmaz, Y. Erdem. Acute kidney injury in the elderly population. Int Urol Nephrol, 42(1):259-271, (2009) (SCI-EXP). 6. Ersoy O, Yilmaz R, Arici M, Turgan Ç, Bayraktar Y. Prevalance of occult hepatitis B infection in hemodialysis patients. Dialysis & Transplantation 9:1-4 (2008) (SCI-EXP). 7. Balaban YH, Simsek H, Yilmaz R, Sarer-Yurekli BP, Shorbagi A, Tatar G. Tumor markers in familial Mediterranean fever and their correlation with the frequency of attacks. Clin Exp Rheumatol, 26(4 Suppl 50):114-6 (2008) (SCI). 8. Kirkpantur A, Yilmaz R, Abali G, Arici M, Altun B, Aki T, Erkan I, Bakkaloglu M, Yasavul U, Turgan C. Utility of C2 Monitoring in Prediction of Diastolic Dysfunction in Renal Transplant Recipients. Transplant Proc, 40(1):171-173, (2008) (SCI). 9. Kirkpantur A, Yilmaz R, Baydar DE, Aki T, Cil B, Arici M, Altun B, Erdem Y, Erkan I, Bakkaloglu M, Yasavul U, Turgan C. Utility of the Doppler ultrasound parameter, resistive index, in renal transplant histopathology. Transplant Proc, 40(1):104-6 (2008) (SCI). 10. Genctoy G, Ozbek M, Avcu N, Kahraman S, Kirkpantur A, Yilmaz R, Kansu O, Arici M, Altun B, Erdem Y, Bakkaloğlu M, Yasavul U, Turgan C, Kansu H. Gingival Health Status in Renal Transplant Recipients: Relationship between Systemic Inflammation and Atherosclerosis. Int J Clin Pract, 61(4):577-82, (2007) (SCI). 11. Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol, 19(1):50-6, (2006) (SCI-EXP). 12. Kahraman S, Yilmaz R, Akinci D, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C. U-shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patients. J Ren Nutr, 15(4):377-86, (2005) (SCI-EXP). 13. Kirkpantur A, Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C. The Effects of Maintenance Recombinant Human Erythropoietin Therapy on Ambulatory Blood Pressure Recordings: Conventional, Doppler, and Tissue Doppler Echocardiographic Parameters. Artif Organs, 29(12):965-972, (2005) (SCI). 14. Kahraman S, Yilmaz R, Kirkpantur A, Genctoy G, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C. Impact of rHuEPO Therapy Initiation on Soluble Adhesion Molecule Levels in Haemodialysis Patients. Nephrology (Carlton), 10(3):264-269, (2005) (SCI-EXP). 15. Altun B, Yilmaz R, Kahraman S, Genctoy G, Arici M, Onalan O, Oto A, Hayran M, Bakkaloglu M, Yasavul U, Turgan C. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant-recipients. Transpl Int, 18(6):681-9, (2005) (SCI). 16. Kahraman S, Yilmaz R, Genctoy G, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C. Efficacy and safety of intravenous iron therapy for HCV-positive Haemodialysis patients. Nephron Clin Pract, 100(3): 78-85 (2005) (SCI). 17. Kahraman S, Genctoy G, Cil B, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, Bakkaloglu M, Turgan C, Caglar S. Prediction of renal allograft function with early Doppler ultrasonography. Transplant Proc, 36(5):1348-51, (2004) (SCI). 18. AA Kutlugün, M Arıcı, T Yıldırım, D Turgut, R Yılmaz, M Altındal, B Altun, Y Erdem, Ü Yasavul, Ç Turgan. Daily Sodium Intake in Chronic Kidney Disease Patients during Nephrology Clinic Follow-Up: An Observational Study with 24-Hour Urine Sodium Measurement. Nephron Clin Pract 2011;118:c361–c366 (SCI). 19. Aybal Kutlugun A, Altun B, Buyukasik Y, Aki T, Turkmen E, Altindal M, Yildirim T, Yilmaz R, Turgan C. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients? Transpl Int. 2012 Jan; 25(1):13-8 (SCI). 20. AA Kutlugün, B Altun, U Aktan, E Turkmen, M Altindal, T Yildirim, R Yilmaz, M Arici, Y Erdem, C Turgan. The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients. Amyloid, 2012; 19(1): 28–32 (SCI). 21. Yildirim T, Kocak T, Buyukasik Y, Yilmaz R, Altun B, Erdem Y, Arici M. Are low-molecular-weight heparins appropriately dosed in patients with CKD stage 3 to 5? Blood Coagul Fibrinolysis. 2012 Dec;23(8):700-4. doi: 10.1097/MBC.0b013e328356717f. PubMed PMID: 23135378 (SCI). 22. Yildirim T, Arici M, Piskinpasa S, Aybal-Kutlugun A, Yilmaz R, Altun B, Erdem Y, Turgan C. Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern? Ren Fail. 2012;34(9):1095-9. doi: 10.3109/0886022X.2012.717478 (SCI-EXP) 23. Altun B, Yilmaz R, Aki T, Akoglu H, Zeybek D, Piskinpasa S, Uckan D, Purali N, Korkusuz P, Turgan C. Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes. Am J Nephrol. 2012;35(6):531-9. doi: 10.1159/000339167, (SCI). 24. Piskinpasa S, Altun B, Akoglu H, Yildirim T, Agbaht K, Yilmaz R, Peynircioglu B, Cil B, Aytemir K, Turgan C. An Uninvestigated Risk Factor for Contrast-Induced Nephropathy in Chronic Kidney Disease: Proteinuria. Ren Fail. 2012 Nov 23. PubMed PMID: 23176376 (SCI-EXP). 25. Akoglu H, Seringec N, Yildirim T, Yilmaz R, Okutucu S, Turkmen E, Evranos B, Kaya EB, Dikmenoglu N, Arici M, Erdem Y, Turgan C. Relationship between hemorheology and endothelial dysfunction in renal transplant patients receiving calcineurin inhibitors. J Nephrol. 2012 Nov 13:0. doi: 10.5301/jn.5000237 PubMed PMID: 23147686 (SCI-EXP). 26. H. Akoglu, T. Yildirim, G. Eldem, G. Arik, R. Yilmaz, A.A. Kutlugun, T. Hazirolan, F.T. Aki, M. Arici, Y. Erdem, C. Turgan. Living Donor Kidney Volume as a Predictor of Graft Function: Is There a Role for Proteinuria? Transplant Proc. 2013 Jan-Feb;45(1):77-81. doi: 10.1016/j.transproceed.2012.10.020 (SCI). 27. Ceri M, Unverdi S, Senes M, Altay M, Yilmaz R, Yucel D, Duranay M. Serum soluble fas ligand levels in familial Mediterranean fever. Ren Fail. 2013 May 17. [Epub ahead of print DOI: 10.3109/0886022X.2013.794660 (SCIEXP). 28. Unverdi S, Ceri M, Unverdi H, Yilmaz R, Akcay A, Duranay M Postpartum persistent proteinuria after preeclampsia: a single-center experience Wien Klin Wochenschr. 2013 Feb;125(3-4):91-5. doi: 10.1007/s00508-013-0320-8. Epub 2013 Jan 19 (SCI). 29. Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK; AVOID Study Investigators. Collaborators (351). Aliskiren combined with losartan in type 2 diabetes and nephropathy. NEJM 2008; 5;358(23):2433-46. A.2. SCI, SCI EXPANDED, SSCI VE AHCI KAPSAMINDAKI DERGILERDE YAYINLANAN VAKA RAPORU, TEKNIK NOTLAR VE BENZERI YAZILAR 1. Özaslan E, Yilmaz R, Simsek H, Tatar G. Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother, 36(11):1715-8 (2002) (SCI). 2. Yilmaz R, Akoglu H, Kirkpantur A, Kilickap S, Arici M, Altun B, Aki T, Erdem Y, Yasavul U, Turgan C. A Novel Immunosuppressive Agent, Sirolimus, in the Treatment of Kaposi's Sarcoma in a Renal Transplant Recipient. Ren Fail, 29(1):103-105, (2007) (SCI-EXP). 3. Akoglu H, Yilmaz R, Kirkpantur A, Arici M, Altun B, Turgan C. Combined Organ Failure with Combination Antihyperlipidemic Treatment: A Case of Hepatic Injury and Acute Renal Failure. Ann Pharmacother, 41(1):143-7, (2007) (SCI). 4. Agbaht K, Pepedil F, Kirkpantur A, Yilmaz R, Arici M, Turgan C. A Case of Kaposi's Sarcoma Following Treatment of Membranoproliferative Glomerulonephritis and a Review of the Literature. Renal Fail, 29(1):107-110, (2007) (SCIEXP). 5. Akoglu H, Yilmaz R, Peynircioglu B, Arici M, Kirkpantur A, Cil B, Altun B, Turgan C. A Rare Complication of Hemodialysis Catheters: Superior Vena Cava Syndrome. Hemodial Int, 11(4):385-391, (2007)(SCIEXP). 6. Koca E, Buyukasik Y, Cetiner D, Yilmaz R, Sayinalp N, Yasavul U, Uner A. Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts. Leuk Res, 32(3):495-9, (2008) (SCI). 7. Akinci D, Turkbey B, Yilmaz R, Akpinar E, Ozmen MN, Akhan O. Percutaneous treatment of pyocystis in patients with autosomal dominant polycystic kidney disease. Cardiovasc Intervent Radiol, 31(5):926-30 (2008) (SCIEXP). 8. Koçak E, Köklü S, Akbal E, Huddam B, Azak A, Yilmaz SR. Development of glomerulonephritis early in the course of Crohn’s disease. Inflamm Bowel Dis, 16(4): 548-9, (2010) (SCI). 9. Koçak G, Koçak E, Yılmaz ŞR, Köklü S, Duranay M, Yalçın F, Albayrak Y. MEFV gene mutations in patient with eosinophilic gastroenteritis: A case report. Southern Medical Journal 2010 Nov;103(11):1170-2 (SCI) 10. M Ceri, S Unverdi, M Altay, R Yılmaz, M Duranay. An unusual effect of colchicine treatment in Familial Mediterranean Fever-associated glomerulonephritis Rheumatol Int (2011) 31:971–972 (SCI). 11. M Ceri, S Unverdi, M Altay, H Unverdi, I Kurultak, R Yılmaz, A Ensari, M Duranay. Focal segmental glomerulosclerosis in association with Gitelman syndrome Int Urol Nephrol (2011) 43: 905–907 (SCI EXP) 12. M. Ceri, L. Ortabozkoyun, M. Altay, S. Unverdi, I. Kurultak, B. Huddam, F. Kilic, R. Yilmaz, M. Duranay. Peritonitis Due to Pseudomonas stutzeri, an Organism That May Be Difficult to Culture. Perit Dia Int 2010; 30,4: 484-486 (SCI) 13. S Unverdi, M Ceri, MA Öztürk, E Akbal, A Ensari, R Yilmaz, E Kocak, S Inal, S Koklu, M Duranay A Patient with Crohn’s Disease who Presented with Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome Renal Failure, 33(2): 244–245, (2011) (SCI EXP) 14. T Yildirim, R Yilmaz, DE Baydar, AA Kutlugun, T Aki, C Turgan. Lansoprazole-induced acute allergic interstitial nephritis in a renal transplant recipient: a case report Int Urol Nephrol 2012, (SCI EXP) 15. M Arhan, S Köklü, F Yalçın, H Batgi, SR Yılmaz, O Yüksel. Severe Intestinal Bleeding in a Patient with Wegener's Granulomatosis. The American Journal of Gastroenterology 104, 2119-2120 (2009) (SCI). A.3. Uluslararası kongrelerde sunulan, SCI, SCI Expanded, kapsamındaki dergi özel sayılarında veya aynı kapsamlardaki kongre kitabında tam metni veya özeti yayınlanmıs bildiriler 1. Yıldız B, Yılmaz R, Bayraktar M, Hamaloğlu E: The value of preoperative localization studies in primary hyperparatiroidism. Journal of Endocrinological Investigation; 23 (supp 7), P-147, (2000). 2. Kav T, Yılmaz R, Bayraktar Y, Abbasoğlu O: Megaduodenum Due to Hollow Visceral Myopathy Mimicking SMA Syndrome: A case Report. Hepato-Gastroenterology, 48 (supp 1), P-110, (2001). 3. Simsek H, Yılmaz R, Balaban Y, Tatar G: Tumor markers in FMF: Increased CA 72-4 levels in patients with frequent attacks. Clinical and Experimental Rheumatology, 20 (supp 26) A-33, (2002). 4. Tatar G, Yılmaz R, Balaban Y, Simsek H: Association of helicobacter pylori infection with familial mediterranean fever disease. Clinical and Experimental Rheumatology, 20 (supp 26) A-34, (2002). 5. Altun B, Gençtoy G, Kahraman S, Yılmaz R, Arıcı M, Erdem Y, Yasavul U, Turgan Ç, Bakkaloğlu M, Çağlar Ş. Insulin resistance, hyperlipidemia and inflammatory markers in renal transplant recipients: Association with TGF-β1, TNF-α and IL-10 Genotypes. J American Soc of Nephrol, 14: SU 546, (2003). 6. Kahraman S, Gençtoy G, Yılmaz R, Dizdar Ö, Arıcı M, Altun B, Erdem Y, Yasavul U, Turgan Ç, Bakkaloğlu M, Çağlar Ş. What does determine homocystein levels in hemodialysis patients: Nutrition or Inflammation? J American Soc of Nephrol, 14: F-PO775, (2003). 7. Arıcı M, Kahraman S, Gençtoy G, Yılmaz R, Kırkpantur A, Altun B, Erdem Y, Yasavul U, Turgan Ç, Bakkaloğlu M, Çağlar Ş. Constant vs Intermittent CRP elevations: Does it have an impact on survival of hemodialysis patients? J American Soc of Nephrol, 14: SU-PO829 (2003). 8. Kahraman S, Gençtoy G, Yılmaz R, Arıcı M, Altun B, Kirazlı S, Erdem Y, Yasavul U, Turgan Ç, Bakkaloğlu M, Çağlar Ş. Increased adhesion molecules in hemodialysis patients: Interaction with cardiovascular, inflammatory, nutritional and genetic factors. Nephrology Dialysis Transplantation, 18 (supp 4): W548 (2003). 9. Yılmaz R, Kahraman S, Gönen C, Gençtoy G, Arıcı M, Altun B, Erdem Y, Yasavul U, Turgan Ç, Bakkaloğlu M, Çağlar Ş. An audit of hypertension management in patients hospitalized in internal medicine wards: Is it optimal? European Society of Hypertension Abstract Book, 171 (2003). 10. KAHRAMAN S., ARICI M., GENCTOY G., YILMAZ R., ALTUN B., KIRKPANTUR A., YASAVUL U., CAGLAR S.. Metabolic determinants of pulse pressure in hemodialysis patients. American Society of Hypertension Nineteenth Annual Scientific Meeting, 18-22 May 2004. American Journal of Hypertension, volume 17, 2004, P432, 192A. 11. Kahraman S, Duman AE, Yılmaz R, Gençtoy G, Arıcı M, Altun B, Erdem Y, Turgan Ç. How much white coat effect is superimposed on ambulatory blood pressure monitoring results? American Journal of Hypertension 2004; 17:36 P-8. 12. Kahraman S, Altun B, Yılmaz R, Gençtoy G, Arıcı M, Kırkpantur A, Erdem Y, Çağlar Ş. Does restoring serum albumin have an impact on pulse pressure in malnourished hemodialysis patients? XLI Congress of the European Renal Association European Dialysis and Transplant Association 2004, Abstract Book SP–400. 13. Gençtoy G, Yılmaz R, Kahraman S, Altun B, Özbek M, Avcı N, Yasavul U, Çağlar Ş. Chronic periodontal disease in renal transplant recipients: Effects on systemic inflammation and carotid atherosclerosis. XLI Congress of the European Renal Association European Dialysis and Transplant Association 2004, Abstract Book SP-556. 14. Kahraman S, Gençtoy G, Yılmaz R, Kırkpantur A, Arıcı M, Altun B, Turgan C, Çağlar Ş. Adynamic bone disease: Association with malnutrition, inflammation and atherosclerosis. XLI Congress of the European Renal Association European Dialysis and Transplant Association 2004, Abstract Book MP-238. 15. Yılmaz R, Kahraman S, Altun B, Gençtoy G, Akıncı D, Özer N, Erdem Y, Turgan C. Cytokine gene polymorphism and progression of cardiovascular disease in hemodialysis patients: One-year follow up. XLI Congress of the European Renal Association European Dialysis and Transplant Association 2004, Abstract Book MP-316. 16. Yılmaz R, Kahraman S, Altun B, Gençtoy G, Akıncı D, Özer N, Arıcı M, Erdem Y, Turgan C. Effects of amlodipine and ramipril on left ventricul mass index and carotid atherosclerosis in hemodialysis patients. XLI Congress of the European Renal Association European Dialysis and Transplant Association 2004, Abstract Book MP-359. 17. ARICI M., YILMAZ R., KIRKPANTUR A., ALTUN B., ERDEM Y.. ACE inhibitors vs. Angiotensin Receptor Blockers (ARBs): Any effect on potassium in chronic hemodialysis (hd) patients. American Society of Nephrology Congress, 8-13 November 2005, Philadelphia, USA. Journal of the American Society of Nephrology volume 16 (Abstract issue), 2005, SA-PO806, 732A. 18. Yılmaz R, Altun B, Sahiner L, Arıcı M, Erdem Y, Turgan C. B type natriuretic peptide a novel cardiovascular prognostic markers in hemodialysis patients. Nephrology Dialysis Transplantation 2005: 20 (supp-2): 26. 19. Arıcı M, Altun B, Büyükasık Y, Yılmaz R, Kırkpantur A, Kirazli Ş, Turgan C. Antiplatelet factor 4/heparin antibodies prevalance and clinical implications in hemodialysis. Nephrology Dialysis Transplantation 2005: 20 (supp-2): 191 20. Arıcı M, Yılmaz R, Kalyoncu U, Kahraman S, Altun B, Erdem Y, Yasavul U, Turgan C. Association of elevated calcium X phosphate product with an increase in cellular adhesion molecules: A mortality analysis. Nephrology Dialysis Transplantation 2005: 20 (supp-2): 304. 21. Yılmaz R, Kırkpantur A, Arıcı M, Altun B, Erdem Y, Turgan C. Effects of increased ultrafiltration on B type natriuretic peptide and C reactive protein: Does hypervolemia mediates cardiac dysfunction and inflammation in hemodialysis. Nephrology Dialysis Transplantation 2005: 20 (supp-2): 26. 22. Yılmaz R, Altun B, Kırkpantur A, Sahiner L, Arıcı M, Erdem Y, Yasavul U, Bakkaloğlu M, Aki T, Turgan C. Impact of cytokine gene polymorphisms on cardiovascular risk in renal transplant recipients: One-year follow-up study. XLIII Congress of the European Renal Association European Dialysis and Transplant Association 2006, Abstract Book MP-640. 23. Kırkpantur A, Yılmaz R, Aki T, Bakkaloğlu M, Altun B, Arıcı M, Erdem Y, Yasavul U, Turgan C. Serum lipid profile and arterio-venous fistula thrombosis risk: A retrospective study on reverse epidemiology. XLIII Congress of the European Renal Association European Dialysis and Transplant Association 2006, Abstract Book MP-494. 24. Önal İK, Altun B, Yılmaz R, Kırkpantur A, Arıcı M, Oz SG, Erdem Y, Yasavul U, Turgan C. Serum matrix metalloproteinase 2, 9 and tissue inhibitor of metalloproteinase 1 levels in mild hypertensive patients: Effect of blood pressure treatment. XLIII Congress of the European Renal Association European Dialysis and Transplant Association 2006, Abstract Book MP-012. 25. Yılmaz R, Kırkpantur A, Akoğlu H, Arıcı M, Altun B, Erdem Y, Yasavul U, Turgan C. Cystatin C is a novel marker for estimating GFR: Is it purely indicator in renal transplant recipients? XLIII Congress of the European Renal Association European Dialysis and Transplant Association 2006, Abstract Book MP-016. 26. Arıcı M, Koçak T, Büyükasık Y, Yılmaz R, Kırkpantur A, Kirazli Ş, Turgan C. Are low molecular weight heparins appropriately dosed in patients with CKD stage 3 to 5? XLIII Congress of the European Renal Association European Dialysis and Transplant Association 2006, Abstract Book MP-283. 27. Kırkpantur A, Altun B, Yılmaz R, Hazirolan T, Arıcı M, Erdem Y, Yasavul U, Turgan C. The association of bone mineral density with coronary artery calcification in maintanence hemodialysis patients. XLIII Congress of the European Renal Association European Dialysis and Transplant Association 2006, Abstract Book MP-431 28. Yılmaz R, Kırkpantur A, Altun B, Akoğlu H, Aki T, Erdem Y, Yasavul U, Turgan C. The role of inflammatory activity and atherosclerosis on thrombosed arterio-venous fistula for hemodialysis access. Nephrology Dialysis Transplantation 2007: 22 (supp-6):159 (FP417). 29. Kırkpantur A, Yılmaz R, Akoğlu H, Arıcı M, Altun B, Erdem Y, Yasavul U, Turgan C. Proton pump inhibitor use and bone mineral densitometry in maintenance hemodialysis patients. Nephrology Dialysis Transplantation 2007: 22 (supp-6):159 (FP462). 30. Kırkpantur A, Yılmaz R, Ertoy D, Aki T, Arıcı M, Altun B, Erdem Y, Yasavul U, Erken I, Bakkaloğlu M, Turgan C. The utility of the doppler ultrasound parameter, resistive index in renal transplant histopathology. Nephrology Dialysis Transplantation 2007: 22 (supp-6):159 (SaP121). 31. Yılmaz R, Kırkpantur A, Deniz A, Ciftci O, Altun B, Arıcı M, Erdem Y, Yasavul U, Turgan C. Persistent elevation of inflammation marker C reactive protein is associated with atherosclerosis and left ventricular hypertrophy in chronic hemodialysis patients: 2 year follow-up study. Nephrology Dialysis Transplantation 2007: 22 (supp-6):159 (SaP237). 32. Kırkpantur A, Altun B, Yılmaz R, Hazirolan T, Aki T, Arıcı M, Erdem Y, Erkan I, Bakkaloğlu M, Yasavul U, Turgan C. The association between coronary artery calcification, arteriovenous fistula thrombosis and bone mineral density in maintenance hemodialysis patients: Is serum fetuin-a level the missing link? Nephrology Dialysis Transplantation 2007: 22 (supp-6):159 (SaP282). 33. Kırkpantur A, Yılmaz R, Emmungil H, Hazirolan T, Arıcı M, Altun B, Erdem Y, Yasavul U, Turgan C. Sleep duration coronary artery calcification and inflammation in maintenance hemodialysis patients. Nephrology Dialysis Transplantation 2007: 22 (supp-6):159 (SaP296). 34. Kırkpantur A, Yılmaz R, Kerimoğlu Ü, Hazirolan T, Arıcı M, Altun B, Erdem Y, Yasavul U, Turgan C. Ultrasonographic lower limb enthesitis score predicts coronary artery calcification in maintenance hemodialysis patients. Nephrology Dialysis Transplantation 2007: 22 (supp-6):159 (SaP321). 35. Kırkpantur A, Yılmaz R, Abalı G, Arıcı M, Altun B, Aki T, Erkan I, Bakkaloğlu M, Erdem Y, Yasavul U, Turgan C. Utilıty of C2 monitoring in prediction of diastolic dysfunction in renal transplant recipients. Nephrology Dialysis Transplantation 2007: 22 (supp-6):159 (SaP452). 36. Kırkpantur A, Yılmaz R, Hazırolan T, Abalı G, Arıcı M, Altun B, Erdem Y, Yasavul U, Turgan C. The relation between serum fetuin-A concentrations, coronary artery calcification and left ventricular function in patients on haemodialysis: A cross-sectional study. 45 th Congress of European Renal Association European Dialysis and Transplantation Association. Stockholm, Sweden (SP305), May 10-13, 2008. 37. Yılmaz R, Altun B, Yildirim T, Piskinpasa S, Arıcı M, Erdem Y, Yasavul U, Turgan C. Impact of cytokine gen polymorphisms on renal allograft function: 5 year follow up. 45 th Congress of European Renal Association European Dialysis and Transplantation Association. Stockholm, Sweden (SP476), May 10-13, 2008. 38. Yılmaz R, Altun B, Yildirim T, Piskinpasa S, Arıcı M, Erdem Y, Yasavul U, Turgan C. Dieatary salt intake was related to markers of inflammation and proteinuria in primary hypertensive patients. 45 th Congress of European Renal Association European Dialysis and Transplantation Association. Stockholm, Sweden (MO055), May 10-13, 2008. 39. Piskinpasa SV, Altun B, Aybal A, Yildirim T, Yılmaz R, Peynircioğlu B, Çil B, Aytemir K, Özkutlu H, Turgan Ç. An uninvestigated risk factor for contrast induced nephropathy: proteinuria. The World Congress of Nephrology Milan, Italy, Clinical Kidney Journal Vol 2, suppl 2, p13, May 22-26,2009. 40. Akoğlu H, Yıldırım T, Eldem G, Kutlugün AA, Altındal M, Yılmaz R, Hazırolan T, Aki FT, Arıcı M, Turgan Ç. Living Donor Kidney volume as a predictor of graft Function: Is there a Role for Proteinuria? Journal of American Society of Nephrology Renal Week, Denver, Colorado; Abstract Supplement, 105 A (SAFC458), 2010. 41. Yilmaz R, Altun B, Akoğlu H, Piskinpasa SV, Arici M, Çetinkaya DU, Korkusuz P, Purali N, Aki FT, Turgan C. Mesenchymal stem cells and darbepoetin ameliorate acute kidney injury. Journal of American Society of Nephrology Renal Week, Denver, Colorado; Abstract Supplement, 344 A (FPO1016), 2010. 42. Kutlugün AA, Altun B, Akman Ü, Akı T, Turkmen E, Yildirim T, Altındal M, Yılmaz R, Erdem Y. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients? 48th ERA-EDTA Congress, 23-26 June 2011; Praque, Czech, Clinical Kidney journal Vol 4, suppl 2, 2011. 43. Arıcı M, Akoğlu H, Yıldırım T, Seringec N, Türkmen E, Kaya EB, Yilmaz R, Dikmenoğlu N, Erdem Y. Relationship between hemorheology and endothelial dysfunction in Cyclosporine A or Tacrolimus treated renal transplant recepients. The Kidney Week 2012, San Diego CA, JASN Abstract suppl. 858A. 44. Özkayar N, Altun B, Yildirim T, Yilmaz R, Dede F, Hayran M, Arici M, Erdem Y. Relationship between blood pressure values, blood pressure variability and endothelial function in renal transplant recipients. ERA-EDTA 50. Congress İstanbul 2013,Abstract book, SP020. 45. Yildirim T, Yilmaz R, Azak A, Altundal M, Türkmen E, Arıcı M, Altun B, Duranay M, Erdem Y. Blood pressure and residual renal function in peritoneal dialysis: Role of local renin angiotensin system activation. ERA-EDTA 50. Congress İstanbul 2013,Abstract book, SP473. 46. Yilmaz Z, Yildirim T, Yilmaz R, Kutlugün AA, Altun B, Küçüközkan T, Erdem Y. Local renin angiotensin system activation in preeclampsia. ERA-EDTA 50.Congress İstanbul 2013,Abstract book, SP037. 47. Yildirim T, Yilmaz R, Türkmen E, Abudalal A, Altındal M, Ertoy D, Erdem Y. Urinary procollagen predicts degree of renal fibrosis in renal transplant recipients. ERA-EDTA 50.Congress İstanbul 2013,Abstract book, MP649. 48. Yildirim T, Yilmaz R, Altındal M, Türkmen E, Arıcı M, Altun B, Erdem Y. Endothelial Dysfunction in renal transplant recipients role of vitamin D and fibroblast growth factor-23. ERA-EDTA 50.Congress İstanbul 2013,Abstract book, MP636. A.4.B. Diğer (ISI kapsamı dışındaki) uluslararası indeksler kapsamındaki dergilerde yayınlanan yazılar 1. Kahraman S, Yilmaz R, Genctoy G, Kirkpantur A, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C, Caglar S. Obesity in Hemodialysis Patients: Is it an Innocent Phenomenon? BANTAO Journal, 1 (2):151-153, (2003).

Kidney Failure Transplantation Hemodialysis Hypertension

: (312) 305 17 10

: ryilmaz@hacettepe.edu.tr